19 Comments

"Our unique success in vaccine development and mass production — notably beating out our main rival, China"

I'd like to see a whole article (from Noah or anyone really) about how the US -- "can't do infrastructure", "bad at mass manufacturing", "no industrial base", etc -- seems to have beaten China soooooooo badly on this one. The R&D? Okay, sure, expected the US to do better there. Even if its own population is hesitant to get vaccinated ... why isn't China able to produce a billion shots and do REAL vaccine diplomacy? Instead I keep reading stories like how Thailand ordered 2 million shots of Sinovac and 90 million shots of AstraZeneca. Or the Philippines got a mere 500,000 shots of Sinovac for their population of 110,000,000, good for half of 1% of the country.

I mean, we're 5 months into 2021 at this point. I'm pretty sure that Chinese factories can build iPhones faster than this. I hear stories like "China is building one gigabattery factory a week" or how China directed state capitalism is good at quickly executing mega-projects. So what's the full story here?

Expand full comment

I'm not exactly sympathetic to very strong IP rights, but I've heard that loosening (even temporarily) international IP protections for COVID vaccines wouldn't do much good for developing countries because:

- LMICs that have production capacity tend to be middle-income so they don't need the IP restrictions waived (idk about this, there are still a lot of very poor people in middle-income countries).

- LMICs that don't have production capacity wouldn't benefit from an IP waiver, at least not directly. (However, they could still benefit from lower vaccine prices coming from other countries.)

Another possible argument against waiving IP for developing countries (which I haven't heard but am making up on the spot) is that it's still an incentive for pharmas to develop vaccines that are well-suited to distribution in LMICs. For example, the Oxford-AstraZeneca vaccine ended up being a good fit for LMICs (although they've agreed to sell it to LMICs at cost, in perpetuity).

What do you think of these counterarguments?

Also, your Bloomberg link over the text "waive intellectual property rights for other countries" doesn't say anything about IP rights for vaccines. Is that the wrong link?

Expand full comment

Yes, vaccine diplomacy is an obvious way for the US to outcompete China and prove the superiority of the liberal democratic approach (we must never forget the way authoritarian China treated its own doctor who tried to warn people about COVID).

Expand full comment

hi I am from India. India has two Vaccines it currently manufactures 1. AZ- Covidshield, 2 Indigenous -VoVaxin, and there is no raw material shortage for the above two and we expect significant ramp up in production and vaccination in May. in addition Indian companies have started to manufacture Russian vaccine "Sputnik 5" so India can manage without US help... but the fact is US help... the raw material shortage is for the fourth vaccine "Covocax" which is licensed from Novavax an American company.. it is a mRNA based vaccine. the production for "Covocax" is towards India's contribution to "GAVI" a WHO initiative to provide vaccine's to Africa and South America. so in short US is blocking vaccines for poor countries ... Lastly you notice india has licensed all the vaccine it makes... and by manufacturing at a global scale... it can bring down the cost of vaccine for entire world... the waiver in IP is for other countries... the current cost estimate for vaccination of Indian population is 0.4% of GDP... which we can afford...

PS: India has provided free vaccine to USA's neighbor's in Caribbean, south America and Canada. ..also last year when there was HCQ and PPE shortage India provided it globally including USA...

Expand full comment

> Still, our failure to sell Canada doses early on probably damaged our relations with them a little

I think the damage is more than 'a little'. The idea that Canada has to import vaccines from Europe rather than from the largest-trading-partner United States rankles the entire political system. The right wing uses it as a club against the centre-left government ("if you had done a good job, we'd all be vaccinated by now"), and the left wing uses it to argue against free trade generally ("why did governments ever allow biotech companies to leave" / "nationalize biotech")

This isn't even a one-off; it comes on the heels of the Trump administration using frivolous 'national security' grounds to penalize Canadian steel and aluminum. The only lesson for the Canadian political elite to take from this is that on matters of national importance, the United States is a competitor rather than a partner.

Expand full comment

Welcome to Team Vax the Planet, Noah!

Citations Needed ran an episode earlier this year (https://citationsneeded.libsyn.com/episode-129-vaccine-apartheid-us-medias-uncritical-adoption-of-racist-intellectual-property-dogma) about the overrating of "intellectual property" and how it feeds into the deadly denial of vaccines and medicines to poorer countries.

Transcript available over at Substack 1.0 (https://citationsneeded.medium.com/episode-129-vaccine-apartheid-us-medias-uncritical-adoption-of-racist-intellectual-property-b7fed9e288e6) for people who prefer to just read.

Expand full comment

I would love to use the vaccines to help other countries in the Americas. It has the added benefit of helping the immigration crisis in the US that we have almost 0 willpower to tackle in a comprehensive way, and is one of the few areas that needs drastic improvement that wouldn't be helped by the expected "infrastructure" package. I'm mainly focused on Central America and South America, not so much about Mexico (though they should be part of it too).

Expand full comment

That link to Bloomberg about waiving IP is the wrong link.

Expand full comment

The problem with India and Mexico first is that they're so big - by the time we get enough vaccines to them, I'm sure Canada and Japan will be well on their way.

Expand full comment

We sometimes forget that the US also shares a "border" of sorts with the islands of the Caribbean. The US has significant security and economic interests in the region, which is also highly dependent on Tourism and has therefore taken a greater economic battering than most. It therefore surprises me that in addition to Canada and Mexico, the US authorities have not extended their vaccine largesse to this region.

Expand full comment

China doesn’t need to manufacture the vaccines as they solved the COVID problem with lockdowns. India has ordered 100 mill doses of Sputnik, it we can help them but probably not more than Russia.

Expand full comment